dokumendiregister.ee
Sissetulev kiriAvalik

Euroopa farmakopöa töökava asjus

Ravimiamet · 5. märts 2025
Viit
REP-1/1202-1
Registreeritud
5. märts 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: teisipäev, 18. veebruar 2025 12:28 Adressaat: Signe Leito Teema: Survey: proposed addition of a new monograph on Emtricitabine to the Ph. Eur. work programme : EDQM-2025-00746-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-00746-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of the monograph on Emtricitabine to the work programme of Group 10C. In order to have access to the survey, please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=177741&lang=en Deadline for replies: 13 March 2025. Thank you. With kind regards On behalf of Sylvina Iossiphova ___ Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store 1 Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00746-mail 2
Allikas: Ravimiamet dokumendiregister →